Spots Global Cancer Trial Database for advanced malignant tumor
Every month we try and update this database with for advanced malignant tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors | NCT05198505 | Advanced Malign... | TQB2868 Injecti... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor | NCT05089461 | Advanced Malign... | Mitoxantrone Hy... | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies | NCT04954456 | Advanced Malign... | QLS31901 | 18 Years - 75 Years | Qilu Pharmaceutical Co., Ltd. | |
| QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors | NCT04326829 | Advanced Malign... | QL1604 | 18 Years - 80 Years | Qilu Pharmaceutical Co., Ltd. | |
| Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors | NCT05851092 | Advanced Malign... | HRS-2189 Tablet... | 18 Years - | Shandong Suncadia Medicine Co., Ltd. | |
| RT201(Tumor Antigen-specific Macrophage Tumor Vaccine) | NCT05930301 | Cervical | 18 Years - 75 Years | Wuxi People's Hospital | ||
| A Study of QL1706 in Subjects With Advanced Malignant Tumor | NCT04296994 | Advanced Malign... | QL1706 | 18 Years - | Qilu Pharmaceutical Co., Ltd. | |
| A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors | NCT04975204 | Advanced Malign... | TQB3909 Tablets | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| RT201(Tumor Antigen-specific Macrophage Tumor Vaccine) | NCT05930301 | Cervical | 18 Years - 75 Years | Wuxi People's Hospital | ||
| A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors | NCT04975204 | Advanced Malign... | TQB3909 Tablets | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors | NCT04975204 | Advanced Malign... | TQB3909 Tablets | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors | NCT06059508 | Advanced Malign... | SHR-5495 for in... | 18 Years - 70 Years | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | |
| QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors | NCT04326829 | Advanced Malign... | QL1604 | 18 Years - 80 Years | Qilu Pharmaceutical Co., Ltd. | |
| RT201(Tumor Antigen-specific Macrophage Tumor Vaccine) | NCT05930301 | Cervical | 18 Years - 75 Years | Wuxi People's Hospital | ||
| An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor | NCT04739111 | Advanced Malign... | Human Anti-PD-L... | 18 Years - | Dragonboat Biopharmaceutical Company Limited | |
| Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies | NCT05042908 | Advanced Malign... | LBL-003 Injecti... | 18 Years - 75 Years | Nanjing Leads Biolabs Co.,Ltd | |
| Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors | NCT05851092 | Advanced Malign... | HRS-2189 Tablet... | 18 Years - | Shandong Suncadia Medicine Co., Ltd. | |
| A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors | NCT05144061 | Advanced Malign... | HRS2398 Tablets | 18 Years - 70 Years | Shanghai Hengrui Pharmaceutical Co., Ltd. | |
| QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors | NCT04326829 | Advanced Malign... | QL1604 | 18 Years - 80 Years | Qilu Pharmaceutical Co., Ltd. | |
| Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors | NCT05416359 | Advanced Malign... | TQB3915 tablets | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor | NCT05015309 | Advanced Malign... | SH3765 tablet | 18 Years - | Nanjing Sanhome Pharmaceutical, Co., Ltd. | |
| BAT7104 Injection in Patients With Advanced Malignant Tumors. | NCT05767060 | Advanced Malign... | BAT7104 injecti... | 18 Years - 80 Years | Bio-Thera Solutions | |
| Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors | NCT05198505 | Advanced Malign... | TQB2868 Injecti... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors | NCT04975204 | Advanced Malign... | TQB3909 Tablets | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| An Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor | NCT04739111 | Advanced Malign... | Human Anti-PD-L... | 18 Years - | Dragonboat Biopharmaceutical Company Limited |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
